UCMSCC

Fuzhou General Hospital · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	UCMSCC
Sponsor	Fuzhou General Hospital
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Mesenchymal Stem Cells in Central Nervous System injury2017 (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

UCMSCC CI brief — competitive landscape report
UCMSCC updates RSS · CI watch RSS
Fuzhou General Hospital portfolio CI